Glover, CA
Andrew James Glover, Belle River CA
Patent application number | Description | Published |
---|---|---|
20140042680 | COMPOSITE LEAF SPRING AND METHOD OF MAKING SAME - A leaf spring manufactured from composite material has a variable cross sectional area. The leaf spring is manufactured by die forming a core of a constant cross section, then winding fibres onto the core to create a spring with a variable cross section and then cutting the spring to size. A ply lay-up station is shown which winds fibre onto a die formed workpiece as it moves through the station. | 02-13-2014 |
Barbara Glover, Toronto CA
Patent application number | Description | Published |
---|---|---|
20080302582 | Easy to Use and Intuitive User Interface for a Remote Control - The present invention is a system and method for an easy to use and intuitive user interface on a remote control. In one embodiment of the present invention, a touch sensitive area is extended beyond a screen. In one embodiment, soft buttons lie partially on the screen and partially off it (on the extended touch-sensitive area). This allows for an increased input area for the user, without the increase in cost associated with a larger screen. Moreover, this allows for a smooth, flat, and sleek upper surface of the remote control. In one embodiment of the present invention, a remote control provides different user experiences based upon the context of use of the remote control. For instance, the color of the screen as well as the color of backlighting for certain buttons is dependent upon what mode the remote control is in. | 12-11-2008 |
Brett Glover, Vancouver CA
Patent application number | Description | Published |
---|---|---|
20140272898 | SYSTEM AND METHOD OF PROVIDING COMPOUND ANSWERS TO SURVEY QUESTIONS - Embodiments disclosed herein include systems and methods which allow for the creation of online surveys in which answers to compound questions may be efficiently gather from online survey respondents using a space-efficient user interface configuration. The space-efficient user interface configuration reduces the perceived and/or actual time and effort needed to complete the survey, and allows the user to easily review previously submitted questions. | 09-18-2014 |
James Andrew Glover, Whitby CA
Patent application number | Description | Published |
---|---|---|
20100007888 | Multiple path length transmittance measuring device - A device to measure the amount of light able to transmit through a test liquid sample. A single lamp is used to illuminate a liquid sample cell containing the test water. A light detector is fixed relative to the lamp and is used to detect the amount of light from the lamp able to transmit through the liquid sample cell. The liquid sample cell is shaped in such a way as to provide at least two sets of opposed side walls that are able to transmit the light emitted from the lamp, where each set of opposed side walls defines a different path length through the liquid sample in the liquid sample cell. A rotation mechanism is used to provide relative rotation between the liquid sample cell and the lamp/light detector assembly. A microprocessor connected to the light detector calculates the light transmitted through at least two different path lengths through the liquid sample. Using these calculated transmittances the microprocessor then calculates the overall transmittance of the test water. | 01-14-2010 |
20120162651 | APPARATUS AND METHOD FOR MEASURING TRANSMITTANCE - A device to measure the amount of light able to transmit through a liquid. The device uses a light detector and light source mounted to a support mechanism such that the detector and light source define a path of light emitted by the light source and detected by the detector. The device uses a structure designed to surround a liquid to be tested such that the structure allows light to transmit through the structure and the liquid. An actuator engenders relative motion between the support mechanism and the structure such that at certain times the light propagating between the light source and the detector passes substantially through the structure and the liquid to be tested such that the amount of light able to transmit through the liquid is detected by the detector, and at other times the light propagates directly from the light source to the detector without passing through the structure or the liquid such that the amount of light emitted from the light source is directly detected by the detector. A microprocessor then uses the two sets of detector readings to allow the transmittance measurement of the liquid to be compensated for errors introduced by drift and fluctuations in the amount of light emitted by the light source and also by drift in the light detector and electronics. Such fluctuation and drift is very common in light sources and is due primarily to changes in temperature and imperfections in the light source itself and the power supply. | 06-28-2012 |
Michael Glover, Perth CA
Patent application number | Description | Published |
---|---|---|
20120318475 | Building Energy System - There is disclosed a building energy system comprising a building enclosure having an insulated building envelope that incorporates at least one perimeter fenestration assembly, and an integrated mechanical system that provides heating and cooling. The integrated mechanical system comprises a cold thermal storage tank, a hot thermal storage tank, and a heat pump that transfers heat from the cold thermal storage tank to the hot thermal storage tank. The building enclosure also comprises an air stratified ventilation system comprising at least one upper exhaust outlet and at least one lower supply intake. The upper exhaust outlet incorporates a heat exchanger that recovers heat from outgoing air. The heat exchanger is connected to the cold thermal storage tank. Energy performance of the at least one fenestration assembly may vary or be automatically controlled such that the heating and cooling loads of the integrated mechanical system are at least partially balanced. | 12-20-2012 |
Michael Glover, Ontario CA
Patent application number | Description | Published |
---|---|---|
20100300645 | BUILDING ENERGY SYSTEM - There is disclosed a building energy system comprising a building enclosure having an interior and exterior. The building enclosure comprises an insulated building envelope that incorporates perimeter windows with a centre-of-glass R-value of R-4 or higher, at least one upper exhaust outlet and at least one lower supply intake that connect to the exterior of the building enclosure, and at least one central space that is connected to the lower supply intake and one or more perimeter rooms located adjacent to the central space. Each perimeter room comprises one or more lower wall vents that connect to the central space, and one or more upper vents connected to the upper exhaust outlet. The upper exhaust outlet incorporates a regulator to minimize ventilation air heat loss while maintaining indoor air quality. The regulator may comprise an automated damper and a motorized fan selectively operated based at least in part on measurements of air pollution contaminants. There is also provided a variable solar control window panel comprising coating or coatings on a number of possible glazing surfaces of a multiple glazed window. The coating or coatings comprises thin film multi-layer optical interference filters configured to selectively block solar radiation in depending upon an incidence angle of sunlight on the glazing surface. | 12-02-2010 |
Nicholas R. Glover, Oakville CA
Patent application number | Description | Published |
---|---|---|
20090075878 | Methods for Generating and Screening Fusion Protein Libraries and Uses Thereof - The invention provides methods for generating fusion protein libraries, such as immunotoxin libraries. The invention also relates to libraries of recombinant cells encoding nucleic acid sequences comprising fusion proteins. In addition, the invention relates to the libraries themselves and the use of the libraries to screen for fusion proteins that are specific for target cells, such as cancer cells. Further, the invention relates to methods of improving fusion proteins and to the improved fusion proteins. | 03-19-2009 |
20150018526 | Cytotoxins comprising modified bouganin toxin for the treatment of cancer - The invention provides modified forms of bouganin protein having biological activity and a reduced propensity to activate human T cells as compared to the non-modified bouganin protein. The invention also provides T-cell epitope peptides of bouganin, and modified T-cell epitope peptides of bouganin which have a reduced propensity to activate human T cells as compared to the non-modified T-cell epitope peptide. The invention also provides cytotoxins having the having a ligand that binds to a cancer cells attached to the modified bouganin proteins. Also provided are methods of inhibiting or destroying mammalian cancer cells using the cytotoxins of the invention and pharmaceutical compositions for treating human cancer. | 01-15-2015 |
Nicholas Ronald Glover, Oakville CA
Patent application number | Description | Published |
---|---|---|
20100254982 | CANCER SPECIFIC ANTIBODY AND CELL SURFACE PROTEINS - The present invention provides the amino acid and nucleic acid sequences of heavy chain and light chain complementarity determining regions of a cancer specific antibody. In addition, the invention provides cancer specific antibodies and immunoconjugates comprising the cancer specific antibody attached to a toxin or label, and methods and uses thereof. The invention also relates to diagnostic methods and kits using the cancer specific antibodies of the invention. Further, the invention provides a novel cancer-associated antigen and its uses thereof. | 10-07-2010 |
20120128723 | CANCER SPECIFIC ANTIBODY AND CELL SURFACE PROTEINS - The present invention provides the amino acid and nucleic acid sequences of heavy chain and light chain complementarity determining regions of a cancer specific antibody. In addition, the invention provides cancer specific antibodies and immunoconjugates comprising the cancer specific antibody attached to a toxin or label, and methods and uses thereof. The invention also relates to diagnostic methods and kits using the cancer specific antibodies of the invention. Further, the invention provides a novel cancer-associated antigen and its uses thereof. | 05-24-2012 |
20130217865 | Tumor Specific Antibody - The present invention provides the amino acid and nucleic acid sequences of heavy chain and light chain complementarity determining regions of a tumor specific antibody. In addition, the invention provides tumor-specific antibodies and immunoconjugates comprising the tumor-specific antibody attached to a toxin or label, and methods and uses thereof. The invention also relates to diagnostic methods and kits using the tumor-specific antibodies of the invention. | 08-22-2013 |
20140178417 | METHODS FOR TREATING CANCER USING AN IMMUNOTOXIN - The present invention relates to methods for preventing or treating head and neck spuamous cell cancer and bladder cancer using an immunotoxin comprising (a) a ligand that binds to a protein on the cancer cell attached to; (b) a toxin that is cytotoxic to the cancer cell. In a specific embodiment, the invention is directed to the prevention or treatment of head and neck squamous cell cancer or bladder cancer using Vb4-845, which is a recombinant immunotixin comprising a humanized, MOC31-derived, single-chain antibody fragment that is fused to a truncated form of | 06-26-2014 |
Nicholas Ronald Glover, Ontario CA
Patent application number | Description | Published |
---|---|---|
20080219994 | MODIFIED BOUGANIN PROTEINS, CYTOTOXINS AND METHODS AND USES THEREOF - The invention provides modified forms of bouganin protein having biological activity and a reduced propensity to activate human T cells as compared to the non-modified bouganin protein. The invention also provides T-cell epitope peptides of bouganin, and modified T-cell epitope peptides of bouganin which have a reduced propensity to activate human T cells as compared to the non-modified T-cell epitope peptide. The invention also provides cytotoxins having the having a ligand that binds to a cancer cells attached to the modified bouganin proteins. Also provided are methods of inhibiting or destroying mammalian cancer cells using the cytotoxins of the invention and pharmaceutical compositions for treating human cancer. | 09-11-2008 |
20100249039 | Methods for Treating Cancer Using an Immunotoxin - The present invention relates to methods for preventing or treating head and neck squamous cell cancer and bladder cancer using an immunotoxin comprising (a) a ligand that binds to a protein on the cancer cell attached to; (b) a toxin that is cytotoxic to the cancer cell. In a specific embodiment, the invention is directed to the prevention or treatment of head and neck squamous cell cancer or bladder cancer using VB4-845, which is a recombinant immunotoxin comprising a humanized, MOC31-derived, single-chain antibody fragment that is fused to a truncated form of | 09-30-2010 |
20100254964 | Modified Bouganin Proteins, Cytotoxins and Methods and Uses Thereof - The invention provides modified forms of bouganin protein having biological activity and a reduced propensity to activate human T cells as compared to the non-modified bouganin protein. The invention also provides T-cell epitope peptides of bouganin, and modified T-cell epitope peptides of bouganin which have a reduced propensity to activate human T cells as compared to the non-modified T-cell epitope peptide. The invention also provides cytotoxins having the having a ligand that binds to a cancer cells attached to the modified bouganin proteins. Also provided are methods of inhibiting or destroying mammalian cancer cells using the cytotoxins of the invention and pharmaceutical compositions for treating human cancer. | 10-07-2010 |